
Sign up to save your podcasts
Or


Research shows that women remain woefully underrepresented at the highest levels of leadership in the life sciences industry. Those who have broken through that glass ceiling, however, are not only doing groundbreaking work in pharma, biotech, medtech and beyond but also reframing what it means to be a leader in the sector—as evidenced by the often-unconventional career paths and management philosophies of the 10 women featured in this year’s Fiercest Women in Life Sciences report.
In this week’s episode of “The Top Line,” Fierce’s Andrea Park and Gabrielle Masson dive into the report, highlighting several honorees’ paradigm-busting approaches to leadership, mentorship and building inclusive teams.
To learn more about the topics in this episode:
2025's Fiercest Women in Life Sciences
4 reasons life sciences still fail women at the top, despite a female-majority workforce: report
GSK's Emma Walmsley to step down as CEO in shock move, giving way to commercial lead Luke Miels
Merck KGaA, grappling with geopolitical tensions, reveals CEO transition
Takeda taps Julie Kim to take over for retiring CEO Christophe Weber
See omnystudio.com/listener for privacy information.
By Fierce Life Sciences4
1111 ratings
Research shows that women remain woefully underrepresented at the highest levels of leadership in the life sciences industry. Those who have broken through that glass ceiling, however, are not only doing groundbreaking work in pharma, biotech, medtech and beyond but also reframing what it means to be a leader in the sector—as evidenced by the often-unconventional career paths and management philosophies of the 10 women featured in this year’s Fiercest Women in Life Sciences report.
In this week’s episode of “The Top Line,” Fierce’s Andrea Park and Gabrielle Masson dive into the report, highlighting several honorees’ paradigm-busting approaches to leadership, mentorship and building inclusive teams.
To learn more about the topics in this episode:
2025's Fiercest Women in Life Sciences
4 reasons life sciences still fail women at the top, despite a female-majority workforce: report
GSK's Emma Walmsley to step down as CEO in shock move, giving way to commercial lead Luke Miels
Merck KGaA, grappling with geopolitical tensions, reveals CEO transition
Takeda taps Julie Kim to take over for retiring CEO Christophe Weber
See omnystudio.com/listener for privacy information.

30,695 Listeners

3,230 Listeners

975 Listeners

1,928 Listeners

1,643 Listeners

1,093 Listeners

324 Listeners

1,037 Listeners

224 Listeners

6,057 Listeners

33 Listeners

147 Listeners

19 Listeners

77 Listeners

148 Listeners